SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No. 1
H&Q HEALTHCARE INVESTORS
-------------------------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
-------------------------------------------
(Title of Class of Securities)
404052-10-2
-------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]
- --------------------------------------------------------------------------
1. Name and I.R.S. Identification No. of Reporting Person:
Yale University
I.R.S. Number 06-0646973-N
- --------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a) [ ] (Not Applicable)
(b) [ ] (Not Applicable)
- --------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------
4. Citizenship or Place of Organization
Yale University is a Connecticut Corporation
- --------------------------------------------------------------------------
Number of Shares 5. Sole Voting Power 1,281,822
Beneficially Owned by --------------------------------------------
Each Reporting 6. Shared Voting Power (Not Applicable)
Person With: --------------------------------------------
7. Sole Dispositive Power 1,281,822
--------------------------------------------
8. Shared Dispositive Power (Not Applicable)
- --------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,281,822
- --------------------------------------------------------------------------
10. Check box if the Aggregate Amount in Row (9) Excludes Certain Shares
(Not Applicable)
- --------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
14.3%
- --------------------------------------------------------------------------
12. Type of Reporting Person
EP
- --------------------------------------------------------------------------
Page 1 of 3
<PAGE>
Item 1. Issuer:
(a) Name of Issuer:
H&Q Healthcare Investors (the "Company")
(b) Address of Issuer's Principal Executive Office:
H&Q Capital Management Incorporated
50 Rowes Wharf -- 4th Floor
Boston, MA 02110-3328
Item 2. Person Filing:
(a) Name of Person Filing:
Yale University
(b) Address of Principal Business Office:
Yale University
Investments Office
230 Prospect Street
New Haven, CT 06511-2107
(c) Citizenship:
Yale University is a Connecticut corporation.
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
404052-10-2
Item 3. Status of Person Filing:
If this statement is filed pursuant to rules 13d-1(b) or 13d-2(b),
check whether the person filing is a:
. . . .
(f) [X] . . . Endowment Fund; see section 13d-1(b)(1)(ii)(F)
. . . .
Item 4. Ownership:
(a) Amount Beneficially Owned:
1,281,822
(b) Percent of Class:
14.3%
Page 2 of 3
<PAGE>
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote:
1,281,822
(ii) shared power to vote or to direct the vote:
(Not Applicable)
(iii) sole power to dispose or to direct the disposition of:
1,281,822
(iv) shared power to dispose or to direct the disposition
of:
(Not Applicable)
Item 5. Ownership of Five Percent or Less of a Class:
(Not Applicable)
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
(Not Applicable)
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company:
(Not Applicable)
Item 8. Identification and Classification of Members of Group:
(Not Applicable)
Item 9. Notice of Dissolution of Group:
(Not Applicable)
Item 10. Certification:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose
of and do not have the effect of changing or influencing the
control of the issuer of such securities and were not acquired in
connection with or as a participant in any transaction having
such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Date: April 9, 1997
/s/ David F. Swensen
---------------------------
Signature
Name: David F. Swensen
Title: Chief Investment Officer
Page 3 of 3
